648 results on '"Katsanos, Konstantinos H"'
Search Results
2. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
3. Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial
4. Can Hypnotherapy Be Considered a Valuable Component in the Management of Inflammatory Bowel Disease? Insights from a Comprehensive Review
5. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study
6. Ocular manifestations in celiac disease: an overview
7. Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies
8. Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece
9. Biomarker Development in Chronic Inflammatory Diseases
10. Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study
11. Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
12. DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making
13. Inflammatory bowel disease and atrial fibrillation: a contemporary overview
14. The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
15. DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making
16. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
17. Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
18. Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases
19. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study
20. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
21. The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
22. SURGICAL INTERVENTION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY BOWEL DISEASE AND PERIANAL DISEASE
23. Minimally Invasive Surgical Approaches for Pancreatic Adenocarcinoma: Recent Trends
24. Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis
25. Correction to: Ocular manifestations in celiac disease: an overview
26. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
27. Translation and validation of questionnaires: necessary processes for inflammatory bowel disease studies reliability
28. Changes of serum adhesion molecules and cytokines in post-ERCP pancreatitis: Adhesion molecules and cytokines in acute pancreatitis
29. Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
30. Sexual Dysfunction in Patients With Inflammatory Bowel Disease
31. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn’s disease
32. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohnʼs and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
33. Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease
34. Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
35. European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
36. The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience
37. European evidence based consensus for endoscopy in inflammatory bowel disease
38. Orbital and optic nerve complications of inflammatory bowel disease
39. Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]
40. Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative Statistics
41. Inflammatory bowel disease and lupus: A systematic review of the literature
42. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: A 15-year single center experience
43. Medical, Endoscopic and Surgical Management of Stricturing Crohn’s Disease: Current Clinical Practice
44. The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease
45. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study
46. Prevalence of inflammatory bowel disease related dysplasia and cancer in 1500 colonoscopies from a referral center in northwestern Greece
47. Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease
48. Increased fatigability of external anal sphincter in inflammatory bowel disease: Significance in fecal urgency and incontinence
49. Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature
50. Neurologic manifestations in inflammatory bowel diseases: Current knowledge and novel insights
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.